Lexicon Pharmaceuticals Inc (LXRX)
1.185
-0.02
(-1.66%)
USD |
NASDAQ |
Nov 05, 16:00
1.18
0.00 (0.00%)
After-Hours: 20:00
Lexicon Pharmaceuticals Shareholders Equity (Quarterly): 239.98M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 239.98M |
March 31, 2024 | 288.87M |
December 31, 2023 | 93.11M |
September 30, 2023 | 139.51M |
June 30, 2023 | 186.36M |
March 31, 2023 | 88.05M |
December 31, 2022 | 117.12M |
September 30, 2022 | 144.02M |
June 30, 2022 | 70.83M |
March 31, 2022 | 92.70M |
December 31, 2021 | 113.60M |
September 30, 2021 | 136.60M |
June 30, 2021 | 137.23M |
March 31, 2021 | 152.55M |
December 31, 2020 | 156.37M |
September 30, 2020 | 87.64M |
June 30, 2020 | -10.69M |
March 31, 2020 | 54.78M |
December 31, 2019 | 117.10M |
September 30, 2019 | 164.71M |
June 30, 2019 | -64.89M |
March 31, 2019 | -45.69M |
December 31, 2018 | -26.40M |
September 30, 2018 | -29.40M |
June 30, 2018 | -5.071M |
Date | Value |
---|---|
March 31, 2018 | 26.19M |
December 31, 2017 | 68.26M |
September 30, 2017 | 78.38M |
June 30, 2017 | 106.31M |
March 31, 2017 | 134.60M |
December 31, 2016 | 157.40M |
September 30, 2016 | 185.18M |
June 30, 2016 | 217.33M |
March 31, 2016 | 252.88M |
December 31, 2015 | 285.85M |
September 30, 2015 | 197.94M |
June 30, 2015 | 231.47M |
March 31, 2015 | 257.61M |
December 31, 2014 | 284.02M |
September 30, 2014 | 77.82M |
June 30, 2014 | 116.67M |
March 31, 2014 | 140.78M |
December 31, 2013 | 170.16M |
September 30, 2013 | 185.71M |
June 30, 2013 | 215.08M |
March 31, 2013 | 242.21M |
December 31, 2012 | 266.68M |
September 30, 2012 | 252.76M |
June 30, 2012 | 244.90M |
March 31, 2012 | 268.97M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-10.69M
Minimum
Jun 2020
288.87M
Maximum
Mar 2024
126.62M
Average
117.12M
Median
Dec 2022
Shareholders Equity (Quarterly) Benchmarks
Viatris Inc | 19.52B |
AIM ImmunoTech Inc | 6.102M |
Perspective Therapeutics Inc | 341.00M |
Protalix BioTherapeutics Inc | 28.58M |
Armata Pharmaceuticals Inc | -46.10M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 373.36M |
Total Liabilities (Quarterly) | 133.38M |
Debt to Equity Ratio | 0.4146 |
Current Ratio | 11.51 |
Net Debt Paydown Yield | -1.67% |